Form 4: Masimo Corp EVP Acquires Stock Options and Restricted Stock Units
SEC Form 4 Filing
Micah W. Young, EVP & Chief Financial Officer of Masimo Corp, reports acquisition of stock options and restricted stock units.
Summary
- Micah W. Young, the EVP & Chief Financial Officer of Masimo Corporation, filed a Form 4 on March 13, 2025.
- The filing reports the grant of non-qualified stock options and restricted stock units (RSUs) on March 11, 2025.
- Young acquired 7,739 non-qualified stock options with an exercise price of $166.52.
- These options vest over a five-year period, with 20% vesting annually starting March 11, 2026.
- Young also acquired 3,495 restricted stock units, which represent the right to receive one share of Masimo common stock upon vesting.
- These RSUs vest ratably over four years, with 25% vesting annually starting March 11, 2026.
Sentiment
Score: 6
Explanation: The document is a standard regulatory filing related to executive compensation. It doesn't contain overtly positive or negative information, but the granting of equity suggests a degree of confidence in the company's future performance.
Positives
- The grant of stock options and RSUs aligns the executive's interests with those of the shareholders.
- The vesting schedules encourage long-term commitment from the executive.
Future Outlook
The vesting schedules for the stock options and RSUs suggest an expectation of continued service and contribution from the executive over the next four to five years.
Industry Context
Stock options and RSUs are common forms of executive compensation in the technology and medical device industries, used to incentivize performance and retain key personnel.
Comparison to Industry Standards
- Executive compensation packages, including stock options and RSUs, are common in publicly traded companies like Masimo.
- Companies such as Medtronic, Stryker, and Boston Scientific also utilize similar equity-based compensation to align executive interests with shareholder value.
- Vesting schedules of four to five years are typical for these types of awards.
Stakeholder Impact
- Shareholders may view the equity grants as a positive sign, aligning management's interests with their own.
- Employees may see this as a sign of stability and commitment to the company's future.
Key Dates
| Date | Description |
|---|---|
| 03/11/2025 | Date of the transaction (grant of stock options and RSUs) |
| 03/11/2026 | First vesting date for both stock options and RSUs |
| 03/11/2035 | Expiration date for the stock options |
| 03/13/2025 | Date the Form 4 was signed |
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.